Showing results (1-10 of 1,800) with videos related to
Sort By:
Pageof 180
Frontiers in Immunology|April 17, 2023
A close look at current γδ T-cell immunotherapyLing Ma, Yanmin Feng, Zishan ZhouOncology Letters|June 22, 2018
Construction of an anti-programmed death-ligand 1 chimeric antigen receptor and determination of its antitumor function with transduced cellsJiasen Xie, Zishan Zhou, Shunchang Jiao, et al.Proceedings (Baylor University. Medical Center)|April 22, 2009
Acupuncture as a complementary therapy in chemotherapy-induced nausea and vomitingLing MaJournal of Invertebrate Pathology|November 29, 2019
Replacement of loop2 and 3 of Cry1Ai in domain II affects specificity to the economically important insect Bombyx moriYuxiao Liu, Zishan Zhou, Zeyu Wang, et al.Biotechnology Letters|November 4, 2010
Identification of the minimal active fragment of the Cry1Ah toxinJing Xue, Zishan Zhou, Fuping Song, et al.Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
(E)-N'-(3,4-Dimethoxy-benzyl-idene)-2-(8-quinol-yloxy)acetohydrazide-methanol-water (1/1/1)Zhan-Ling MaActa Crystallographica. Section E, Structure Reports Online|March 14, 2012
catena-Poly[(diaqua-cadmium)-μ-4,4'-[sulfonyl-bis-(1,4-phenyl-ene-oxy)]-di-acet-ato-κO,O':O'',O''']Zhan-Ling MaImmunity, Inflammation and Disease|January 27, 2023
Epitope identification for p53R273C mutantJian Zhang, Minglu Liu, Yin Chen, et al.Frontiers in Pharmacology|May 30, 2023
A specific SNP-based multiplex PCR assay for the simultaneous identification of two biological ingredients for the Chinese patent medicine, Danggui Buxue pillYinrong Liu, Yingying Yang, Zishan Zhou, et al.Biochemical and Biophysical Research Communications|March 15, 2018
Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogrammingLing Ma, Qiao ChengPageof 180